+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare Distribution - Global Strategic Business Report

  • PDF Icon

    Report

  • 417 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302566

Global Healthcare Distribution Market to Reach $5.7 Trillion by 2030

The global market for Healthcare Distribution estimated at US$2.3 Trillion in the year 2023, is projected to reach a revised size of US$5.7 Trillion by 2030, growing at a CAGR of 12.1% over the analysis period 2023-2030.

Pharmaceutical, one of the segments analyzed in the report, is projected to record 11.8% CAGR and reach US$2.3 Trillion by the end of the analysis period. Growth in the Biopharmaceutical segment is estimated at 13.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $804.7 Billion, While China is Forecast to Grow at 14.1% CAGR

The Healthcare Distribution market in the U.S. is estimated at US$804.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1 Trillion by the year 2030 trailing a CAGR of 14.1% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 10.1% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 11.8% CAGR.

Exciting New Report Features

  • Full access to influencer engagement stats
  • Free access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 61 Featured)

  • Cardinal Health, Inc.
  • Epicor Software Corporation
  • Henry Schein, Inc.
  • FedEx Corporation
  • Imperial Logistics Group (Pty) Limited
  • HighJump Software, Inc.
  • CenTrak, Inc.
  • Biolog-id
  • Express Scripts Holding Company
  • AmerisourceBergen Corporation
  • Global Healthcare Exchange LLC (Ghx)
  • Alliance Healthcare
  • Cavalier Logistics
  • Intalere
  • Hvantage Technologies Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Healthcare Distribution - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
  • How the Healthcare Industry Has & Continues to be Impacted by the Pandemic & What’s the New Normal?
  • The Biggest & Worst Ever Public Health Crisis in Human History Creates a Mixed Bag of Challenges & Opportunities for the Healthcare Industry
  • With the COVID-19 Pandemic Exposing Global Healthcare Unpreparedness, There is Increasing Policy Led Focus on Rebooting Health Systems Worldwide: Current & Required Healthcare Spending as % of GDP
  • Clinical Diagnostic Laboratories Work Overtime to Manage Giant Waves of COVID Infection Testing Flowing In
  • Global Clinical Diagnostics Market Reset & Trajectory - Growth Outlook (In %) For Years 2019 Through 2025
  • The Pandemic Triggers Shift in Consumer Behavior & Engagement With Healthcare Technologies & Services
  • Healthcare Industry Pushed to Adopt Digital Technologies & Innovate to Save Lives Amid the Crisis
  • Digital Health Technologies Poised to Break New Grounds Post Pandemic: Global Opportunity in Digital Health (In US$ Billion) for Years 2020, 2022, 2024 and 2026
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Substandard Drugs, an Urgent Challenge in the Supply Chain that Begs to be Addressed
  • Pharmaceutical Thefts & Counterfeiting, A Persistent Challenge in Distribution That Eludes Resolution
  • Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs
  • Storming Into the Spotlight Is the Use of Blockchain in Fighting Counterfeiting of Drugs
  • Rising Incidence of Counterfeiting in the Pharmaceutical Industry Pushes Up the Urgency to Leverage the Security Benefits Promised by Blockchain: Global Number of Pharmaceutical Counterfeiting Incidents for Years 2000, 2005, 2010, 2015, 2019 & 2022
  • Serialization Emerges as an Another Weapon in the Arsenal to Battle Counterfeiting
  • Rising Healthcare Costs Drives Attractiveness of e-Pharmacies
  • Here’s How Healthcare Costs Are Outstripping Global GDP: Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
  • Social Distancing Amid the COVID-19 Pandemic Accelerates the Viability & Indispensability of e-Pharmacies, Fast Forwarding Growth by Over 2 Years
  • Global ePharmacy Sales Breakdown (In %) by OTC Drugs & RX Drugs As of the Year 2021
  • Aging Population, Rising Prevalence of Chronic Diseases & Ensuing Demand for Drugs & Medical Equipment Rank as Major Drivers of Growth in the Market
  • Aging Population Steps-Up the Burden On Healthcare Systems Including Distribution: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Rising Prevalence of Chronic Diseases Amplifies Demand for Pharmaceutical Drugs & Distribution: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
  • Robust Demand for Pharmaceutical Drugs Drives Growth in the Market
  • Pharmaceutical Contract Manufacturing, a Barometer of the Growing Demand & Production of Drugs
  • More Drugs Being Manufactured Means More Drugs in Distribution: Global Opportunity for Pharmaceutical Contract Manufacturing (In US$ Billion) for Years 2020, 2022, 2024, and 2026
  • Artificial Intelligence to Revolutionize Pharmaceutical Retailing
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Healthcare Distribution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Biopharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Biopharmaceutical by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Other End Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Other End Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 22: World Healthcare Distribution Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
JAPAN
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
CHINA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
EUROPE
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Healthcare Distribution by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
FRANCE
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
GERMANY
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Spain 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Spain 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Russia 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Russia 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Healthcare Distribution by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Healthcare Distribution by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Healthcare Distribution by Product Type - Pharmaceutical, Biopharmaceutical and Medical Devices Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Healthcare Distribution by Product Type - Percentage Breakdown of Value Revenues for Pharmaceutical, Biopharmaceutical and Medical Devices for the Years 2014, 2024 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Healthcare Distribution by End-Use - Retail Pharmacies, Hospital Pharmacies and Other End Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Healthcare Distribution by End-Use - Percentage Breakdown of Value Revenues for Retail Pharmacies, Hospital Pharmacies and Other End Uses for the Years 2014, 2024 & 2030
AUSTRALIA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Healthcare Distribution Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Cardinal Health, Inc.
  • Epicor Software Corporation
  • Henry Schein, Inc.
  • FedEx Corporation
  • Imperial Logistics Group (Pty) Limited
  • HighJump Software, Inc.
  • CenTrak, Inc.
  • Biolog-id
  • Express Scripts Holding Company
  • AmerisourceBergen Corporation
  • Global Healthcare Exchange LLC (Ghx)
  • Alliance Healthcare
  • Cavalier Logistics
  • Intalere
  • Hvantage Technologies Inc.